Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

RMD open

Showing results (281-290 of 2,087) with videos related to

Pageof 209
Sort By:
RMD Open|September 22, 2021
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extensionKarine Briot, Anthony A Portale, Maria Luisa Brandi, et al.
RMD Open|June 28, 2019
Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritisCarol A Hitchon, Xiaobo Meng, Hani S El Gabalawy, et al.
RMD Open|June 28, 2019
Era of biosimilars in rheumatology: reshaping the healthcare environmentJosef S Smolen, Joao Goncalves, Mark Quinn, et al.
RMD Open|June 28, 2019
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitisVítor Teixeira, Aladdin J Mohammad, Rachel B Jones, et al.
RMD Open|June 28, 2019
Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trialsJeffrey R Curtis, Xavier Mariette, Cécile Gaujoux-Viala, et al.
RMD Open|July 6, 2019
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patientsLaure Gossec, Martin Soubrier, Frantz Foissac, et al.
RMD Open|April 24, 2023
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritisJoeri W van Straalen, Görkem Akay, Carlyn V Kouwenberg, et al.
RMD Open|April 17, 2023
Patient appropriateness for total knee arthroplasty and predicted probability of a good outcomeGillian A Hawker, Eric Bohm, Michael J Dunbar, et al.
RMD Open|March 30, 2021
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this targetTill Uhlig, Lars F Karoliussen, Joseph Sexton, et al.
RMD Open|April 9, 2021
Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort studyUta Kiltz, Aylin Celik, Styliani Tsiami, et al.
Pageof 209

Showing results (281-290 of 2,087) with videos related to

Sort By:
Pageof 209
RMD Open|September 22, 2021
Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extensionKarine Briot, Anthony A Portale, Maria Luisa Brandi, et al.
RMD Open|June 28, 2019
Human host defence peptide LL37 and anti-cyclic citrullinated peptide antibody in early inflammatory arthritisCarol A Hitchon, Xiaobo Meng, Hani S El Gabalawy, et al.
RMD Open|June 28, 2019
Era of biosimilars in rheumatology: reshaping the healthcare environmentJosef S Smolen, Joao Goncalves, Mark Quinn, et al.
RMD Open|June 28, 2019
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitisVítor Teixeira, Aladdin J Mohammad, Rachel B Jones, et al.
RMD Open|June 28, 2019
Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trialsJeffrey R Curtis, Xavier Mariette, Cécile Gaujoux-Viala, et al.
RMD Open|July 6, 2019
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patientsLaure Gossec, Martin Soubrier, Frantz Foissac, et al.
RMD Open|April 24, 2023
Methotrexate therapy associated with a reduced rate of new-onset uveitis in patients with biological-naïve juvenile idiopathic arthritisJoeri W van Straalen, Görkem Akay, Carlyn V Kouwenberg, et al.
RMD Open|April 17, 2023
Patient appropriateness for total knee arthroplasty and predicted probability of a good outcomeGillian A Hawker, Eric Bohm, Michael J Dunbar, et al.
RMD Open|March 30, 2021
12-month results from the real-life observational treat-to-target and tight-control therapy NOR-Gout study: achievements of the urate target levels and predictors of obtaining this targetTill Uhlig, Lars F Karoliussen, Joseph Sexton, et al.
RMD Open|April 9, 2021
Are patients with rheumatic diseases on immunosuppressive therapies protected against preventable infections? A cross-sectional cohort studyUta Kiltz, Aylin Celik, Styliani Tsiami, et al.
Pageof 209